JOURNAL ARTICLE

Trends in the Utilization of Herbal and Dietary Supplements in Patients with Chronic Liver Disease During the SARS-CoV2 Pandemic.

  • Published In: Integrative Medicine: A Clinician's Journal, 2023, v. 22, n. 5. P. 14 1 of 3

  • Database: CINAHL Ultimate 2 of 3

  • Authored By: Kaur, Avleen; Ahyoung Kim; Yanek, Lisa R.; Yisi Liu; Xueting Tao; Peeler, Anna; Mogul, Douglas; Hamilton, James Peter Adam; Mullin, Gerard E. 3 of 3

Abstract

Background: We studied the pattern of herbal and dietary supplement (HDS) use in patients with chronic liver disease (CLD) during the first year of the COVID-19 pandemic. Methods: A questionnaire/survey was sent to hepatology patients with CLD under the care of hepatologists at Johns Hopkins University School of Medicine. Results: The 5 most taken dietary supplements during the pandemic included vitamin B12 (27.7%), vitamin C (32.4%), vitamin D (54.6%), zinc (25.4%) and green tea extract (20.8%). Most participants (82.3%) did not discuss their HDS use with their hepatology providers. Conclusions: Healthcare providers should be mindful of potential HDS use in patients with CLD.

Additional Information

  • Source:Integrative Medicine: A Clinician's Journal. 2023/11, Vol. 22, Issue 5, p14
  • Document Type:Journal Article
  • Subject Area:Nutrition and Dietetics
  • Publication Date:2023
  • ISSN:1546-993X
  • Accession Number:174961763

Looking to go deeper into this topic? Look for more articles on EBSCOhost.